Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203677) titled 'Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)' on Sept. 25.
Study Type: Observational
Primary Sponsor: Brigham and Women's Hospital
Condition:
Type2 Diabetes Mellitus
Atherosclerotic Cardiovascular Disease
Intervention:
Drug: Initiation of tirzepatide
Recruitment Status: Not recruiting
Date of First Enrollment: September 19, 2025
Target Sample Size: 49065
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07203677
Published by HT Digital Content Services with permission from Health Daily Diges...